[go: up one dir, main page]

PE123599A1 - Derivados de bifenilo - Google Patents

Derivados de bifenilo

Info

Publication number
PE123599A1
PE123599A1 PE1998001034A PE00103498A PE123599A1 PE 123599 A1 PE123599 A1 PE 123599A1 PE 1998001034 A PE1998001034 A PE 1998001034A PE 00103498 A PE00103498 A PE 00103498A PE 123599 A1 PE123599 A1 PE 123599A1
Authority
PE
Peru
Prior art keywords
alkyl
alcoxy
compound
refers
group
Prior art date
Application number
PE1998001034A
Other languages
English (en)
Inventor
Robert Swoboda
Esteban Pombo Villar
Manuel Koller
Silvio Ofner
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9723134.4A external-priority patent/GB9723134D0/en
Priority claimed from GBGB9723133.6A external-priority patent/GB9723133D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE123599A1 publication Critical patent/PE123599A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I DONDE R1 Y R2 SON H, ALQUILO C1-C4, ALCOXI C1-C4, ENTRE OTROS; R3 ES H, OH, ALQUILO C1-C4, ALCOXI C1-C4, ENTRE OTROS; R4 ES H, OH, ALCOXI C1-C4; R5 ES UN GRUPO a, b, c, -X-N(R7)(R8); R6 ES ALQUILO C1-C4: X ES ALQUILENO C1-C4; R7 Y R8 SON H, ALQUILO C1-C4, HIDROXIALQUILO C2-C4, FENILALQUILO C1-C4, O FORMAN JUNTO CON N PIRROLIDINILO, PIPERIDINO, PIPERAZINILO O MORFOLINO O UN GRUPO e; Z ES O, CH2, CH2-CH2; R9, R10, R11, R12, R13 Y R14 SON H, HALOGENO, ALQUILO C1-C4, ALCOXI C1-C4. UN COMPUESTO PREFERIDO ES (+)-3-(4-METOXI-4`-TRIFLUOROMETIL-BIFENIL-3-IL)-1-PROPILPIPERIDINA, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I PUEDE SER UTIL PARA EL TRATAMIENTO DE EPILEPSIA, EMBOLIA Y TRAUMA CEREBRAL O ESPINAL
PE1998001034A 1997-11-03 1998-11-02 Derivados de bifenilo PE123599A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9723134.4A GB9723134D0 (en) 1997-11-03 1997-11-03 Organic compounds
GBGB9723133.6A GB9723133D0 (en) 1997-11-03 1997-11-03 Organic compounds

Publications (1)

Publication Number Publication Date
PE123599A1 true PE123599A1 (es) 1999-12-20

Family

ID=26312535

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998001034A PE123599A1 (es) 1997-11-03 1998-11-02 Derivados de bifenilo

Country Status (18)

Country Link
EP (1) EP1037876A1 (es)
JP (1) JP2001521923A (es)
KR (1) KR20010031699A (es)
CN (1) CN1278249A (es)
AR (1) AR016148A1 (es)
AU (1) AU740448B2 (es)
BR (1) BR9813897A (es)
CA (1) CA2308151A1 (es)
CO (1) CO5011067A1 (es)
ID (1) ID24413A (es)
IL (1) IL135580A0 (es)
NO (1) NO20002321D0 (es)
NZ (1) NZ503815A (es)
PE (1) PE123599A1 (es)
PL (1) PL339922A1 (es)
SK (1) SK6412000A3 (es)
TR (1) TR200001122T2 (es)
WO (1) WO1999023073A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041280B2 (en) 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
US6858592B2 (en) 2001-06-29 2005-02-22 Genzyme Corporation Aryl boronic acids for treating obesity
TW200840566A (en) * 2006-12-22 2008-10-16 Esteve Labor Dr Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments
US8642583B2 (en) 2008-10-30 2014-02-04 Janssen Pharmaceutica Nv Serotonin receptor modulators
US8575364B2 (en) 2008-10-30 2013-11-05 Janssen Pharmaceutica Nv Modulators of serotonin receptor
DE102009015697A1 (de) 2009-03-31 2010-10-07 Markus Dr. Heinrich Verfahren zur Arylierung von ringsubstituierten Phenolen und Phenylethern

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2114122A (en) * 1938-04-12 Alcohols and process fob making
DE674968C (de) * 1935-01-15 1939-04-26 Roehm & Haas Company Verfahren zur Herstellung von phenolartigen Aralkylaminoalkoholen
US2040039A (en) * 1935-02-26 1936-05-05 Rohm & Haas Phenolic morpholines
US2485550A (en) * 1946-06-25 1949-10-25 Hoffmann La Roche Quaternary salts of carbamic acid esters of tertiary-hydroxybenzyl-amines
US2493710A (en) * 1947-03-21 1950-01-03 Hoffmann La Roche Carbamic acid esters
US2872477A (en) * 1957-04-05 1959-02-03 Dow Chemical Co alpha-(dialkylamino)-6-phenyl-o-cresol esters
JPS5328150A (en) * 1976-08-25 1978-03-16 Sugai Chemical Ind Co Ltd Novel orthophenyl phenol derivative process for preparing same
DE69019185T2 (de) * 1989-02-08 1995-10-26 Otsuka Pharma Co Ltd Biphenylderivat, eine Nervenzelle herstellendes oder gegen Degeneration schützendes Mittel und ein Verfahren zur Herstellung eines dieses Mittel enthaltenden Phenylderivats.
US5428037A (en) * 1993-04-09 1995-06-27 Syntex Pharmaceuticals, Ltd. Heterocyclic derivatives in the treatment of Ischaemia and related diseases
JPH072655A (ja) * 1993-06-18 1995-01-06 Otsuka Pharmaceut Co Ltd 末梢神経変性修復又は保護剤
SI0707007T1 (en) * 1994-10-14 2002-04-30 Merck Patent Gmbh (R)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)chromane as CNS active agent
EP0793662A1 (en) * 1994-11-23 1997-09-10 Neurogen Corporation Aminomethyl aryl compounds; dopamine receptor subtype selective ligands
IL116249A (en) * 1994-12-12 2003-07-06 Pfizer Nk-1 receptor antagonists for the treatment of neuronal damage and stroke
DE19637237A1 (de) * 1996-09-13 1998-03-19 Merck Patent Gmbh Piperazin-Derivate

Also Published As

Publication number Publication date
KR20010031699A (ko) 2001-04-16
EP1037876A1 (en) 2000-09-27
PL339922A1 (en) 2001-01-15
NZ503815A (en) 2002-05-31
AU1487299A (en) 1999-05-24
AU740448B2 (en) 2001-11-01
WO1999023073A1 (en) 1999-05-14
BR9813897A (pt) 2000-09-26
NO20002321L (no) 2000-05-02
JP2001521923A (ja) 2001-11-13
SK6412000A3 (en) 2000-09-12
IL135580A0 (en) 2001-05-20
NO20002321D0 (no) 2000-05-02
CN1278249A (zh) 2000-12-27
ID24413A (id) 2000-07-20
AR016148A1 (es) 2001-06-20
CA2308151A1 (en) 1999-05-14
CO5011067A1 (es) 2001-02-28
TR200001122T2 (tr) 2000-08-21

Similar Documents

Publication Publication Date Title
PE20030238A1 (es) Uso de los antagonistas del receptor nk-1 para el tratamiento de lesiones cerebrales, espinales y neuronales
AR006720A1 (es) Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende
ES2029812T3 (es) Un procedimiento para preparar alfa-alquil-4-amino-3-quinolina-metanoles y 1-(4-aralquilamino-3-quinolil)alcanonas.
ES2113081T3 (es) 1,4-benzotiazepinas utiles como agentes neurologicos.
ES2119991T3 (es) Aminometil-indanos, -benzofuranos y -benzotiofenos.
NZ528997A (en) Sulfonamides
DE3868329D1 (de) 3-amino-dihydro-(1)-benzopyrane und benzothiopyrane.
PT83300B (pt) Processo para a preparacao de 3-amino-di-hidro-{1}-benzopiranos e benzotiopiranos
PE123599A1 (es) Derivados de bifenilo
DK26289A (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
ES514816A0 (es) "procedimiento para la preparacion de compuestos de 1-fenil-2-aminocarbonilindol".
ES2051886T3 (es) Procedimiento para la obtencion de nuevos derivados de la 3h-1,2,3-triazolo(4,5-d)pirimidina.
ES2148772T3 (es) Tetralinas que tienen un sustituyente fenilo sobre el anillo aromatico y su uso en el tratamiento de la epilepsia, la apoplejia y el trauma cerebral o espinal.
ZA895623B (en) Tetracyclic antidepressants
ES551509A0 (es) Un procedimiento para la preparacion de compuestos aminoheterociclicos
NO973242L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti
DK477783D0 (da) 1,3,4,6,7-11b-hexahydro-7-aryl-2h-pyrazino(2,1-a)-isoquinoliner, fremgangsmade til fremstilling heraf og deres anvendelse som mellemprodukter og laegemidler
ES8103081A1 (es) Procedimiento para la obtencion de diazatriciclos
ES2041644T3 (es) Derivados de n-(piperidilaminocarbonil) quinoleincarboxamida que tienen actividad psicotropica.
ES2099727T3 (es) 8-azabiciclo(3.2.1)octilalquiltiazolidinonas, un procedimiento para su preparacion y su uso como medicamentos.
ES8705405A1 (es) Procedimiento de preparar nuevos derivados morfolinicos
ES8707939A1 (es) Procedimiento para preparar derivados de n-carboxialquil-2--oxo-3-diaril-5,6-triazinas
ES2143453T3 (es) Uso de derivados de dihidropiridina para la profilaxis o el tratamiento de trastornos de la circulacion cerebral.
ATE31924T1 (de) Phenethyl-1-alpha-phenyl-piperidin-3-propannitr l-derivate, ihre herstellung und therapeutische verwendung.
MX9705379A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis vasodilatadora.

Legal Events

Date Code Title Description
FC Refusal